InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Mark Lackner, Chief Scientific Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 3 open-market SEC Form 4 transactions: 0 purchases worth $0 and 3 sales worth $57K, reported from Feb 2, 24 to Feb 3, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 3, 25 | ZNTLZentalis Pharmaceuticals, Inc. | SELL | 14.4K | $1.71 | $25K |
| Jan 2, 25 | ZNTLZentalis Pharmaceuticals, Inc. | SELL | 4.4K | $3.12 | $14K |
| Feb 2, 24 | ZNTLZentalis Pharmaceuticals, Inc. | SELL | 1.6K | $11.54 | $18K |